SCHEMBL6927684

SCHEMBL6927684

CC(C)(C)[C@@H](O)C(=O)N1CCC[C@H]1C(=O)NCc1cc(Cl)ccc1C1CCN1

nearest known ligand 0.73

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
F2 P00734 19/20 0.73
F10 P00742 11/20 0.72
PRSS1 P07477 11/20 0.72
PRSS2 P07478 11/20 0.72
PRSS3 P35030 11/20 0.72
F12 P00748 9/20 0.68
F7 P08709 9/20 0.68
F9 P00740 3/20 0.59
ALDH1A1 P00352 1/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17221964 0.84 F2 (1.00) F2F10PRSS1PRSS2PRSS3
SCHEMBL17221962 0.84 F2 (1.00) F2F10PRSS1PRSS2PRSS3
SCHEMBL20484185 0.84 F2 (1.00) F2F10PRSS1PRSS2PRSS3
SCHEMBL6921523 0.84 F2 (1.00) F2F10PRSS1PRSS2PRSS3
SCHEMBL20567697 0.84 F2 (1.00) F2F10PRSS1PRSS2PRSS3
SCHEMBL15298962 0.81 F2 (1.00) F2F10PRSS1PRSS2PRSS3
SCHEMBL6923431 0.81 F2 (0.79) F2F10PRSS1PRSS2PRSS3
SCHEMBL6923426 0.78 F2 (0.70) F2F10PRSS1PRSS2PRSS3
SCHEMBL6076705 0.78 CYP3A4 (0.70) F2F10PRSS1PRSS2PRSS3
Trifluoroacetic Acid SCHEMBL16426767 0.77 F2 (1.00) F2F10PRSS1PRSS2PRSS3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 23 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0857765-B1 Stabilizing agents for powder paints CIBA SC HOLDING AG (CH) 2003-12-03 EP disclosed
EP-0897958-B1 Stabilisers for powder coatings CIBA SC HOLDING AG (CH) 2003-06-18 EP disclosed
US-6515011-B2 Anticoagulants MERCK & CO., INC. 2003-02-04 US disclosed
US-20020119992-A1 Thrombin inhibitors MERCK & CO., INC. 2002-08-29 US disclosed
EP-0842975-B1 Stabilising polyolefins for long term contact with an extracting medium CIBA SC HOLDING AG (CH) 2002-05-22 EP disclosed
EP-0839623-B1 Stabiliser combination for rotomolding process CIBA SC HOLDING AG (CH) 2001-01-31 EP disclosed
EP-0591102-B1 3-(2-Acyloxyethoxyphenyl)benzofuran-2-ones as stabilizers CIBA SC HOLDING AG (CH) 2000-10-18 EP disclosed
WO-2000043459-A1 CORROSION-INHIBITING COATING COMPOSITIONS FOR METALS CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) 2000-07-27 WO disclosed
EP-0648765-B1 Process for the production of 3-arylbenzofuranones CIBA SC HOLDING AG (CH) 2000-07-12 EP disclosed
EP-0644190-B1 Benzofuran-2-ones as stabilizers CIBA GEIGY AG (CH) 1999-03-17 EP disclosed
EP-0857765-A2 Stabilizing agents for powder paints Ciba SC Holding AG (CH) 1998-08-12 EP disclosed
EP-0842975-A1 Stabilising polyolefins for long term contact with an extracting medium Ciba SC Holding AG (CH) 1998-05-20 EP disclosed
EP-0839623-A1 Stabiliser combination for rotomolding process Ciba SC Holding AG (CH) 1998-05-06 EP disclosed
EP-0707035-A1 HALS phosphorinanes as stabilisers CIBA-GEIGY AG (CH) 1996-04-17 EP disclosed
EP-0685519-A1 Oligomeric HALS-phosphites and HALS-phosphonites as stabilizers CIBA-GEIGY AG (CH) 1995-12-06 EP disclosed
EP-0648765-A1 Process for the production of 3-arylbenzofuranones CIBA-GEIGY AG (CH) 1995-04-19 EP disclosed
EP-0644190-A1 Benzofuran-2-ones as stabilizers CIBA-GEIGY AG (CH) 1995-03-22 EP disclosed
EP-0608198-A1 Cyclic diphenylacetonenitriles as stabilisers CIBA-GEIGY AG (CH) 1994-07-27 EP disclosed
EP-0591102-A1 3-(2-Acyloxyethoxyphenyl)benzofuran-2-ones as stabilizers CIBA-GEIGY AG (CH) 1994-04-06 EP disclosed
EP-0232224-B1 PIPERIDINE COMPOUNDS CIBA-GEIGY AG (CH) 1992-11-25 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020119992-A1 Thrombin inhibitors SERPINC1, F2, TFPI F2 2/4885F10 22/4885PRSS1 116/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.